Overview

Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
A study in healthy volunteers to determine whether different drugs metabolised by the liver have any effects on how NRL972 is processed within the body.
Phase:
Phase 1
Details
Lead Sponsor:
Norgine
Treatments:
Cloxacillin
Ursodeoxycholic Acid